In a recent blog post, Kevin Hart discussed the recent status of NuvaRing® litigation in Missouri. The cases in the Eastern District of Missouri are at the beginning of the discovery period. A case management conference was held on July 21, 2009, where certain initial motions and conferences were discussed. A
NuvaRing® is marketed as a once-a-month, combined contraceptive vaginal ring that provides month-long birth control. It is sold in the United States by Organon USA Inc., a New Jersey corporation with its principal place of business in Roseland, New Jersey, and Organon International, Inc., headquartered in the Netherlands
Hydroxycut®, the group of dietary supplements which claim to be fitness and weight loss aids, have recently been linked to severe, and sometimes life threatening injuries. Recent reports state that these injuries include damage to the liver, kidneys and other internal organs, rhabdomyolysis (severe muscle damage), cardiovascular disorders and even death.
Currently, a large number of cases against bisphosphonate manufacturers have been designated as Mass Tort or Multidistrict Litigation (MDL) cases. Mass Tort cases (in State courts) and MDL’s (in federal courts) are methods of organizing and managing cases involving the same or similar injuries and common defendants. These methods of case management offer an expedient, cost-effective manner for the plaintiffs to pursue their claims.
What are the possible side-effects of bisphosphonate treatment? Studies show that the most commonly reported side-effects of bisphosphonate treatment are: 1) Osteonecrosis of the Jaw; and 2) low-trauma bone fractures.
Bisphosphonates are a class of drugs that drug companies claim promote bone regeneration. Bisphosphonates are commonly sold under various brand names including Fosamax®, Actonel®, Aredia® and Zometa®.
NuvaRing® is purported to be a once-a-month, combined contraceptive vaginal ring that provides month-long birth control by emitting a continuous dose of estrogen and progestin for 21 days. NuvaRing® is manufactured by Organon and Akzo Nobel (now divisions of Schering Plough).
Recently, Fosamax, the popular drug used to treat osteoporosis, has been linked to severe injuries including Osteonecrosis of the Jaw (also known as Fossy Jaw, Dead Jaw and Phossy Jaw), low-energy femur fractures and severe and painful injuries affecting bones, joints and muscles.
